MENU
NBTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nanobiotix SA (NBTX) Earnings Date & Reports

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy... Show more

A.I. Advisor
published Earnings

NBTX is expected to report earnings to rise 210.46% to -39 cents per share on April 28

Nanobiotix SA NBTX Stock Earnings Reports
Q4'25
Est.
$-0.39
Q2'25
Beat
by $0.23
Q4'24
Missed
by $0.39
Q2'24
Est.
$-0.51
Q4'23
Beat
by $0.75
The last earnings report on September 30 showed earnings per share of -12 cents, beating the estimate of -35 cents. With 10.91K shares outstanding, the current market capitalization sits at 997.38M.
View a ticker or compare two or three
NBTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NBTX showed earnings on September 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
60 Rue de Wattignies
Phone
+33 140260470
Employees
102
Web
https://www.nanobiotix.com